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Characterization
Nanobiotechnologies have lately attracted much attention, both from therapeutic and diagnosis perspectives. In
this view, the development of colloidal formulations of biocompatible nanoparticles capable of interacting with
selected cells or tissues raises a particular interest, especially in linkwith cell-based pathologies such as cancer. In
this context, the follow-up of colloidal stability and other physico-chemical features is of foremost relevance. In
this contribution, we have focused our study on hybrid colloids based on biomimetic nanocrystalline apatites
(analogous to those found in bonemineral) stabilized by adsorption of 2-aminoethylphosphate (AEP)molecules;
these nanoparticles being intended to interact with cancer cells either for medical imaging (by conferring lumi-
nescence features to the apatite phase) or for therapeutic purposes. We show that various physico-chemical
characteristics of the suspensions vary with time, including viscosity and mean particle size, suggesting a
progressive structuration of the suspensions. Similar modiﬁcations were also noticed during the puriﬁcation by
dialysis. Finally, we report on preliminary experiments aimed at drying the colloidswhile retaining their capacity
to recover their initial state after re-immersion in aqueousmedium; so as to enable extended storage periods for
the nanoparticles in their dry state while allowing their re-suspension at the time of use. On this matter, the
addition of glucose prior to freeze-drying was found to be an effective way to avoid the formation of aggregates
during drying.
This contribution thus confers additional information relative to the stability of AEP-stabilized biomimetic apatite
colloidal formulations, which proved in previous studies to be of particular relevance for nanomedicine.
1. Introduction
This last decadehaswitnessed tremendous efforts aimed at develop-
ing innovative nanosystems (often formulated as colloids) capable of
interacting with cells and tissues [1–5]. Such systems are especially rel-
evant in the case of cancer pathologies in order to improve the efﬁcacy
of cancer treatmentswhile signiﬁcantly reducing side effects (therapeu-
tic objectives), and also to facilitate early diagnosis therefore limiting
cancer-relatedmortality (diagnosis objectives, e.g., throughmedical im-
aging). In the ﬁeld of cancer diagnosis in particular, detection tech-
niques based on luminescent nanoprobes exhibiting a speciﬁc afﬁnity
for some diseased cells have particularly raised interest in the view of
tumor detection. Many systems of nanoprobes have been considered
to-date for suchmedical imaging abilities, including in particular organ-
ic dyes such as green ﬂuorescence protein or DAPI [6] or semiconductor
quantum dots [7–9], among others. However, toxicity [10,11], photo-
bleaching or ﬂickering effects [12,13] are common limitations to these
systems which are thus not particularly suitable for the analysis of bio-
logical tissues, especially over extended periods of time. In this context,
alternative nanosystems are being investigated, such as lanthanide-
doped inorganic nanoparticleswhich are characterized bynarrowemis-
sion bandwidths, high photochemical stability and long ﬂuorescence
lifetime (up to several milliseconds).
In this view, luminescent colloidal systems based on biomimetic
calcium phosphate apatite nanoparticles (similar to bone mineral
nanocrystals [14]) have been synthesized by soft chemistry [15],
where the luminescence was conferred by substituting some calcium
ions (a few atomic %) by rare-earth elements such as europium or terbi-
um [16]. The idea to use biomimetic apatite particles as colloidal
nanocarriers or nanoprobes is indeed particularly appealing taking
into account the high biocompatible character of such apatites that are
already present in Human's organisms in bones and teeth. In such nano-
crystalline apatite-based systems, the colloidal-like character was
linked to the adsorption [17], on the surface of apatite nanocrystals, of
AEP molecules (2-aminoethylphosphate, a phospholipid moiety [18])
producing electrostatic repulsive effects between neighboring nano-
particles, thus hindering their aggregation. In previous works [15,19],
the synthesis and main physico-chemical characteristics of such
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colloidal nanoparticles (size, morphology, composition and lumines-
cence properties) were investigated, and perspectives in terms of
biological evaluations were commented. For example, the possibility
to target cancer cells thanks to such apatite-based colloids has been
illustrated very recently with the example of breast cancer cells and
folic-acid functionalized apatite nanoparticles [16]. Monoclonal anti-
bodies have also been shown to allow cell targeting approaches [20].
The efﬁcacy of a puriﬁcation of such apatite-based hybrid suspen-
sions by dialysis process was also followed [19], this process being
used to efﬁciently eliminate unreacted chemical species. However, mac-
roscopic changes of the suspension state during this dialysis process
were noticed (but not investigated in detail), resulting in particular in
amore viscous system requiring a subsequent re-suspension treatment.
Taking these considerations into account, we followed in the present
contribution various physico-chemical features of (non-luminescent)
apatite-based suspensions, either before or after puriﬁcation by dialysis,
so as to better understand their physical state and appreciate their sta-
bility behavior.
Based on our results, drying and re-suspension aspects were also
examined. Indeed, generally speaking, despite the advantages of drug
delivery systems or imaging nanoprobes, several works have reported
various potential issues linked to the manipulation of suspensions, in-
cluding complex manufacturing, potential added toxicity due to the
“nano” character of the carriers, and metastability [21–23]. Stability is
indeed one of the critical aspects to take into account for ensuring safety
and efﬁciency of systems used in nanomedicine. The colloidal stability
may be affected by various factors such as the nature of the carrier
and of the drug, its dose, the dispersion medium, the delivery route
(e.g., intravenous, oral, intratumoral, etc.), and of course by production
protocols. Stability issues associated with “nanosuspensions” have
been widely investigated and can be subcategorized as “physical” and
“chemical” stability. Common physical stability issues include in par-
ticular sedimentation/creaming effects, agglomeration, uncontrolled
crystal growth and change of crystallinity state and can also affect the
integrity of the drug or its mode of association with the nanocarrier
(e.g., depending on storage and/or transportation conditions). Indeed,
the large surface area of nanoparticles creates high total surface energy,
which is thermodynamically unfavorable, tending to promote particle
agglomeration so as to minimize the surface energy. The most common
strategy to tackle this issue is to introduce stabilizers to the formulation.
However, the stabilizer selection is known to be very challenging, and in
addition to safety and regulation considerations, the selection of stabi-
lizers is based on their ability to provide wetting to surface of the parti-
cles and offer a barrier to prevent nanoparticles from agglomeration
[24,25]. Thus, the stability of nanoparticles used in nanomedicine for-
mulations remains a very challenging issue during pharmaceutical
developments.
In order to achieve preparationswith shelf life of several years, water
elimination from aqueous dispersions to obtain a dry solid form appears
as the most promising strategy [26]. Freeze-drying technique has al-
ready found applications in the preparation of pharmaceutical powders
with speciﬁc characteristics such as controlled particle size and shape.
The drying process may however be accompanied by an irreversible
agglomeration of adjacent nanoparticles, thus potentially hindering fur-
ther re-dispersion in solution prior to clinical use. The deagglomeration
of the clusters could result of different chemical, hydrodynamic and
mechanical mechanisms. When the forces causing deformation of the
agglomerates exceed the cohesive forces due to interparticle binding,
then agglomerates are expected to break-up into smaller fragments
[27]. Several studies have pointed out that the kinetics of deag-
glomeration of nanoparticles-based powder and the morphology and
rheology of the resulting suspensions strongly depend on physico-
chemicals parameters such as pH for example [28–30]. Another objective
of this work was thus to investigate also drying and re-dispersion pro-
cesses, and to ﬁnd a way to release the primary nanoparticles without
major changes in their physico-chemical characteristics.
2. Materials and methods
2.1. Preparation of biomimetic apatite-based colloids
Apatite-based colloids were obtained by coprecipitation at room
temperature of calcium nitrate and ammonium hydrogen phosphate in
deionized water, at pH 9.5, in the presence of 2-aminoethylphosphate
or “AEP”. The precipitates were then allowed to mature in an oven at
100 °C for 16 h. The starting AEP/Ca molar ratio was set to 1. For each
preparation (25 ml), three aqueous solutions were prepared: solution
(A), 6.25 ml, containing 4.87 mmol of calcium nitrate (Ca(NO3)2 · 4H2-
O), solution (B), 6.25 ml, containing 4.87 mmol of AEP, and solution
(C), 12.5 ml, containing 1.62 mmol of ammonium hydrogenphosphate.
Solution (A) was mixed with solution (B) under constant stirring. The
acidic pH of the resulting solution as well as that of solution (C) were
re-adjusted to 9.5 by addition of ammonia.
2.2. Puriﬁcation by dialysis process
In this study, a tubular cellulose membrane (length: 15 cm, diame-
ter: 3 cm, cutoff: 6000–8000 Da) was used as dialysis membrane, con-
taining 25 ml of the suspension to dialyze. The membrane was held
vertically and introduced in 800 ml of dialysis medium (deionized
water). The washing medium was continually homogenized by me-
chanical stirring, and regularly exchanged by a fresh one (changes
after 4, 8, 22 and 26 h of dialysis) so as to regenerate the concentration
gradient and accelerate the puriﬁcation process. The dialysis process
was carried out at room temperature (25 °C).
When mentioned in the text, reagent grade sodium hexameta-
phosphate (denoted here “HMP”) was added on the colloids after puri-
ﬁcation by dialysis in view of optimal particle dispersion. Typically, 1 ml
of HMP aqueous solution at 0.08 Mwere added to 12.5 ml of the colloi-
dal suspension.
2.3. Freeze-drying and redispersion
The suspensions were dried by freeze-drying. When mentioned in
the text, glucose was added to the medium (150 mg of glucose added
to 13.5 ml suspension, composed of 12.5 ml of colloid and 1 ml of
HMP solution at 0.08 M) prior to the freeze-drying step. This biocom-
patible molecule was selected in view of forming, upon freeze-drying,
a water-soluble solid matrix hindering the agglomeration of adjacent
nanoparticles (as is generally noticed during water elimination from
aqueous suspensions). The dry composite apatite/glucose agglomerates
thus formed upon dryingwere then allowed to be redispersed inwater,
under moderate magnetic stirring (about 300 rpm).
2.4. Physico-chemical characterizations
The crystallographic structure of the powders obtained after freeze-
drying the suspensions was investigated by way of X-ray diffraction
(XRD) using a CPS 120 INEL diffractometer with the Kα1 Cobalt radia-
tion (1.78892 Å). For complementary analyses, Fourier transform infra-
red (FTIR) spectroscopy analyses were performed on a Nicolet 5700
spectrometer, in the wavenumber range 400–4000 cm−1 (resolution
4 cm−1).
The calcium content of the nanoparticles was determined by in-
duced coupled plasma atomic emission spectroscopy, ICP-AES (relative
uncertainty 3%). The amount of mineral phosphate (from apatite) was
measured by colorimetry at λ = 460 nm, using the yellow phospho-
vanado-molybdenum complex [31] (relative uncertainty 0.5%). The
AEP content associated to the colloidal nanoparticles after puriﬁcation
by dialysis (thus after removal of all nitrate counter-ions) was drawn
from nitrogen microanalysis (relative uncertainty 0.4%).
The particle size distributions of the suspensionswere characterized
without any dilution by dynamic light scattering (DLS) using a Zetasizer
Nano ZS (Malvern Instruments Ltd), with a backscattered light (λ =
630 nm, θ = 173°). Punctual zeta potential measurements based on
electrophoresis of the particles were carried out on the same apparatus
using an adapted U-shaped measurement cell. For zeta potential mea-
surements, no dilutionwas performed and the suspensionswere tested
as-prepared (synthesis pH of 9.5) without modiﬁcation of medium.
Measurements of the rheological properties of the suspensionswere
performed with an AR rheometer (TA Instruments) at 25 °C. The sus-
pensions were analyzed by simple shear measurements using a parallel
geometry (gap 1 mm) with serrated plates (diameter 60 mm).
Statistical relevance for the particle size and rheologymeasurements
was tested on the basis of quadruplicate experiments.
3. Results and discussion
3.1. Structural and compositional analyses
The suspensions prepared in this contribution by apatite precipita-
tion in the presence of 2-aminoethylphosphate (AEP) and puriﬁed by
dialysis were ﬁrst characterized by XRD and FTIR analyses. Figs. 1
and 2, respectively, report an XRD pattern and an FTIR spectrum that
are typical of such colloidal nanoparticles, and these data conﬁrmed
the apatitic nature of the particles (main XRD diffraction lines corre-
sponding to hydroxyapatite, space group P63/m (hexagonal), have
been added on Fig. 1).
Chemical analyses, however, indicated that the Ca/Pmole ratio of the
apatite phase was close to 1.42 and thus signiﬁcantly lower than the
value (1.67) found for hydroxyapatite. This ﬁnding points out the
nonstoichiometry of such an apatite phase (closer to bone-like apatite).
The AEP/apatite ratio characteristic of the sample was equal to 0.80. On
the basis of nitrogen titration via elemental analyses, this amount of
AEP was found to correspond to 11 wt.% in the hybrid apatite/AEP sys-
tem. The presence of AEP molecules associated with the apatite phase
was conﬁrmed (Fig. 2) by the presence of an absorption band at
754 cm−1, which is characteristic of the P–O(C) vibration mode in sys-
tems such as Ca(AEP)2where a close interaction between AEPmolecules
(exhibiting one global negative charge at the synthesis pH) and Ca2+
ions is involved, as was discussed in previous works [15,28].
3.2. Surface charge analyses and stability
Zeta potential values obtained with these suspensionswere system-
atically found to be positive (ζ ≈ +12 mV at the synthesis pH of 9.5)
despite some variability, that is in good agreement with the presence
of adsorbed AEP molecules, exposing their ammonium –NH3
+ end-
groups toward the solution (while the phosphate end of the AEP mole-
cule interacts with the Ca2+ ions [32]). It may, however, be noted that
this zeta potential value remains quite low (in absolute value), which
thus does not enable us to describe such suspensions as highly stable,
which is generally considered for absolute values above 30 mV.
3.3. Particle size characterizations
Optical observations (macroscopic), however, indicated that the as-
synthesized colloids did not undergo sedimentation. DLSmeasurements
on such as-prepared suspensions conﬁrmed the nanometer-scale di-
mensions of the particles, with a unimodal size distribution centered
around 30 nm. In order to inspect further the stability of these colloids,
additional DLS measurements were carried out 1, 4, 7 and 15 days after
synthesis (Fig. 3). In all cases, the mean hydrodynamic diameter was
found to remain close to 30–35 nm. Interestingly, although a slight
increase inmean particle size towards 35 nmwas noticed here, no sig-
niﬁcant change could be seen over a period of 2 weeks after synthesis.
3.4. Rheological behavior of the suspensions
Rheological characterization showed that the suspensions had a
rheoﬂuidifying behavior, witnessed by a (nearly exponential) decrease
of the suspension viscosity upon increase of the shear rate: in the
range 0.1 to 0.001 Pa.s for shear rates varying from0 and 300 s−1. How-
ever, the viscosity of the suspensions was found to follow some
evolutional trend, increasing progressively upon ageing, which was
followed over a period of 2 weeks. Moreover, a progressive increase of
shear stress (see Fig. 4) was evidenced, tending towards a threshold
value close to 0.1 Pa (starting value at zero shear rate) after few days
of ageing. These results thus suggest that, although no sedimentation
occurs, a progressive structuration of the suspension happens upon
Fig. 1.XRDpattern for biomimetic apatite-based colloids stabilizedbyAEPmolecules (pre-
pared at 100 °C, and pH 9.5), after dialysis puriﬁcation.
Fig. 2. FTIR spectrum for biomimetic apatite-based colloids stabilized by AEP molecules
(prepared at 100 °C, and pH 9.5), after dialysis puriﬁcation.
Fig. 3. DLS measurements versus time, for biomimetic apatite-based colloids stabilized by
AEP molecules (prepared at 100 °C, and pH 9.5).
ageing, which underlines some limitations in the time-dependent
stability of these suspensions.
3.5. Puriﬁcation of the suspensions by dialysis
In a second step, the colloids stability was examined during the pu-
riﬁcation process of dialysis and analyses of the suspension were done
for increasing durations of dialysis between 0 and 26 h of process. The
follow-up of the particle size distributions versus time (Fig. 5) then
pointed out a noticeable alteration in terms of particle size, marked by
a global increase of the mean diameter of the particles and the appear-
ance upon dialysis of new populations of aggregates around 100 nm
and then 300–600 nm (Table 1). As it can be shown, the particle size
distribution of the suspension quite remains the same after 4 h of dial-
ysis. But after 8 h, aggregates of very different sizes have appeared and a
large peak (σ ≈ 106 nm) centered on medium aggregates sizes
(d2peak ≈ 153 nm) can be observed. Then as the dialysis process goes
on, the particle size distributions highlight the existence of three popu-
lations: primary particles, and two populations of aggregates.
This size effectwas accompanied by a progressive increase of the vis-
cosity of the suspension during the dialysis process as shown in Fig. 6.
During this type of size measurements, the auto-correlation function
of each analysis also gives interesting information about the suspension
and the quality of the results. Then the corresponding correlograms
were veriﬁed too and they indicated the likely presence of larger parti-
cles or aggregates (larger than the upper limit of the apparatus which is
over 6 μm), and of a signiﬁcant polydispersity of the particles at this
stage.
Although the rheoﬂuidifying behavior of the suspension was con-
served at all times during the dialysis process (Fig. 6), the increase in
viscosity may be related to the above-mentioned increase of particle
size,witnessing the evolution of the suspension structuration upon dial-
ysis. In addition to possible dissolution–reprecipitation phenomena
during the dialysis process, these effects may probably be linked to
the desorption of some AEP molecules out of the surface of the apatite
nanocrystals, therefore lowering the strength of electrostatic repulsive
forces at the origin of the limitation of agglomeration. This is indeed
supported by the fact that the relative intensity of the FTIR band at
754 cm−1 related to adsorbed AEP tends to decrease progressively as
the dialysis process progresses (not shown here for the sake of brevity).
Very interestingly, we showed, however, that the addition of a dis-
persing agent involving multiple ionic end-groups, such as sodium
hexametaphosphate, led to the recovery of a size closed to the mean
particle size of the colloidal nanoparticles (asmeasured before dialysis),
i.e., close to 40 nm (Fig. 7). After HMP addition, the observable re-
ﬂuidiﬁcation effect was (as expected) accompanied by a quantitative
decrease of the suspension viscosity, reaching the initial value obtained
before dialysis (Fig. 6). The addition of HMP in the medium, which ex-
hibits 6 negatively charged phosphate “heads,” is indeed likely to inter-
act with the surface of the apatite nanoparticles covered with AEP
molecules and presenting some peripheral positively charged amino
groups. Such an interaction could then probably explain the re-
ﬂuidiﬁcation effect observed, by an increased separation of adjacent
nanoparticles, thus indicative of a re-individualization of the nano-
particles (destruction of the above-mentioned structuration of the sus-
pension). Zeta potential measurements performed on such HMP-
treated colloids indeed pointed out a change in sign of the nanoparticles
in the presence of HMP molecules, typically reaching −16 mV [17].
Fig. 8 shows the typical morphology of nanoparticles obtained, after
synthesis and HMP treatment, as observed by Transmission Electron
Microscopy (TEM).
Taking into account theﬁnal objective of use of such colloids, the sta-
bility of such puriﬁed and HMP-redispersed suspensions was also
checked in a preliminary way by subjecting them to the presence of
(1) albumin (the main protein present in human plasma) at a concen-
tration similar to that found in vivo (i.e. 43 g/l), (2) a solution of simulat-
ed body ﬂuid (SBF) and (3) a mixture of the two. The colloidal stability
was found to be retained at least for one week after such treatments
without any detectable sign of agglomeration or sedimentation thus
suggesting a possible use in contact with plasma.
Fig. 4. Evolution of the rheograms of a nanocrytalline apatite suspension, as a function of
ageing time after synthesis.
Fig. 5. Evolution of the particle size distribution during the dialysis process.
Table 1
Characteristic diameters of the particle size distributions of the suspension during the dialysis process. dipeak (nm) is the mode of the peak i, σ (nm) the standard deviation of dipeak and
Propi (%) is the proportion of intensity of the mode of the peak i comparing to the other modes (Prop1 + Prop2 + Prop3 =100%).
Primary particles Aggregates Agglomerates
d1peak (nm) σ1 (nm) Prop1 (%) d2peak (nm) σ2 (nm) Prop2 (%) d3peak (nm) σ3 (nm) Prop3 (%)
Nondialyzed 35 17 100
Dialysis 4 h 33 19 100
8 h 153 106 100
22 h 27 6 13 106 15 26 531 166 61
26 h 44 14 20 319 89 80
3.6. Drying and redispersion of the particles
The above ﬁndings indicate that some alterations of the suspensions
physico-chemical properties, especially in terms of viscosity and/or
mean particle size, could be noticed and followed upon ageing and/or
during the dialysis puriﬁcation process itself. It was thus interesting at
this point to attempt to dry such suspensions (in viewof signiﬁcantly fa-
cilitating their storage over extended periods of time) while retaining
an ability to be re-suspended in aqueous medium without signiﬁcant
change in particle size. First drying experiments carried out either in a
drying oven or by direct freeze-drying were unsuccessful as they led
to noticeably agglomerated particles in a rather irreversible way,
which was evidenced by a sedimentation of part of the particles, even
upon sonication. These ﬁndingsmay probably be linked to the high sur-
face energy of apatite nanocrystals which are prone to interact strongly
with each other, upon elimination of water, in view of minimizing the
total surface energy of the system [33]. In this context, preliminary ex-
periments were then run by freeze-drying the suspensions after addi-
tion of glucose in the medium (150 mg in 13.5 ml suspension,
composed of 12 ml of colloid and 1 ml of HMP solution at 0.08 M).
The original underlying idea in the use of glucose here is in fact linked
to its water solubility: glucose (if added in sufﬁcient quantity) is indeed
expected to form a solid matrix “embedding” the apatite nanoparticles,
thus hindering their agglomeration upon drying; while re-immersion in
water at the time of use will again liberate the nanoparticles by solubi-
lization of the glucose “embedding” matrix. In this case, re-suspension
was found tobe successful as no sedimentation occurred andDLS exper-
iments revealed that no major change in particle size was detected as
compared to the initial suspension (mean hydrodynamic diameter
close to 40 nm) (Fig. 7). Therefore, the colloidal behavior of the
nanoparticles after redispersion was not affected. These results suggest
that the addition of glucose into the system indeed formed the expected
(water-soluble) matrix around the nanoparticles during the freeze-
drying process, thus preventing their interaction/aggregation. After re-
immersion, the solubilization of glucose then permitted to retrieve indi-
vidual dispersed nanoparticles. These ﬁndings are thus promising in
view of the storage over long periods of time of such colloids (under
their dry state) for the setup of innovative injectable colloids formedical
imaging or intracellular therapeutic applications.
For gaining additional insight on the behavior of such dried suspen-
sions during re-immersion processes, redispersion experiments were
done with varying volumes (thus leading to different conditions of par-
ticle concentrations). The dilution factor, f, was varied between 0.5 and
4 (f being the ratio between the volume of the suspension after
redispersion and the volume of the suspension before freeze-drying).
The evolution of the particle size distributions was characterized by
DLS during the redispersion process and kinetics of redispersion can
be represented by the evolution of the particle mean diameter versus
time as in Fig. 9. It can be concluded that whatever the concentration,
a size close to the primary particles size is reached after about 30 min
of agitation. The decrease in size is ﬁrst very fast (about 5–10 min),
then it still decreasing more slowly and there is a stabilization until
about 30 min. Furthermore, the higher the dilution factor, the faster
the redispersion.
Fig. 6.Comparison of the rheograms for a nanocrytalline apatite suspension after synthesis
(non dialyzed), then at the end of the dialysis process and ﬁnally after the HMP addition.
Fig. 7. Comparison of the particle size distribution on the suspension after synthesis, after
dialysis and the HMP addition and at the end of the redispersion process.
Fig. 8. Effect on particle size of an addition of HMP to the suspension.
Fig. 9. Evolution of the particle mean hydrodynamic diameter during the dispersion
process for three different dilution factors.
These ﬁndings thus indicate that it is possible to store such AEP-
stabilized nanocrystalline apatite suspensions in a dry state, e.g., by
addition of water-soluble glucose prior to the drying process, while
preserving their ability to be redispersed in aqueous medium (and in
varying concentrations) at the time of use. This statement is important
in view of the possible use of such nanosuspensions in nanomedicine
applications.
4. Concluding remarks
In this work, various physico-chemical features of colloidal-like
suspensions formed of apatite nanoparticles functionalized by 2-
aminoethylphosphate were examined. In particular, an evolution of the
suspensions viscosity and/ormeanparticle sizewas evidenced upon age-
ing or during the puriﬁcation process of dialysis, leading to their progres-
sive structuration. The addition of a dispersing agent, in this case sodium
hexametaphosphate, however, enabled us to efﬁciently re-suspend the
nanoparticles after dialysis, and the addition of glucose (a water-
soluble matrix-forming biocompatible molecule) allowed us to freeze-
dry the suspensions while retaining their ability to be re-suspended,
thanks to the formation of a glucose matrix around the particles during
the drying process, thus hindering their agglomeration.
This contribution thus sheds some more light on the physico-
chemistry and colloidal (meta)stability of suspensions prepared from
biomimetic apatite/AEP hybrid compounds, thus unveiling potential
limitations and interests of such biocompatible compounds intended
for medical imaging or intracellular therapeutic applications.
Nomenclature
Latin letters
dipeak mode of the peak i of the particle size distribution (nm)
f dilution factor (−)
Propi proportion of intensity of the mode of the peak i (%)
Greek letters
λ wave length (nm)
θ scattering angle (°)
ζ zêta potential (mV)
σ standard deviation (nm)
Acronyms
AEP 2-aminoethylphosphate
DLS dynamic light scattering
FTIR Fourier transform distribution
HMP hexametaphosphate
ICP-AES induced coupled plasma atomic emission spectroscopy
TEM transmission electron microscopy
XRD X-ray diffraction
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